• Home
  • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  • Home
  • Latest
    • Latest
    • News
    • North America
    • Europe
    • Asia
    • Middle East
    • Global
  • Fortune 500
    • Fortune 500
    • Fortune 500 U.S.
    • Fortune Global 500
    • Fortune 500 Europe
    • Fortune China 500
    • Fortune SEA 500
  • Finance
    • Finance
    • Economy
    • Banking
    • Personal Finance
    • Investing
    • Real Estate
    • Energy
    • Crypto
  • Tech
    • Tech
    • Big Tech
    • Startups & Venture
    • AI
    • Innovation
    • Cybersecurity
  • Leadership
    • Leadership
    • Future Of Work
    • Success
    • C-Suite
    • Workplace Culture
    • CEO Initiative
  • Lifestyle
    • Lifestyle
    • Arts & Entertainment
    • Health
    • Travel & Leisure
    • Education
  • Rankings
    • Rankings
    • Great Place To Work
    • Analytics
  • Multimedia
    • Multimedia
    • Live Media
    • Magazine
    • Newsletters
    • Press Releases
    • Video
    • Podcasts
  1. home
  1. home
  2. Alzheimer's treatment

Alzheimer's treatment

Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease
Health

Breakthrough Alzheimer’s trial results show experimental drug significantly slows the disease

By Michelle Fay Cortez and Bloomberg
September 28, 2022
Vaxxinity CEO says the U.S. needs more vaccine options
MPW

Vaxxinity CEO says the U.S. needs more vaccine options

By Marco Quiroz-Gutierrez
October 13, 2021
Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer
Health

Cassava Sciences—a drugmaker with no products on the market—is currently 2021’s best biotech performer

By Cristin Flanagan and Bloomberg
June 9, 2021
A photo illustration shows a French general practitioner with a stethoscope in a doctor's office in Bordeaux

CDC: Alzheimer’s, Dementia Rate To Double By 2060

By Brittany Shoot
September 20, 2018
US-HEALTH-BIOMEDICAL
Health

World Leaders Want to End Alzheimer’s by 2025. New Clinical Results Show Glimmers of Hope

By Alice Tozer
July 26, 2018
Alzheimers-dementia-brain-research
Health

A Diabetes Drug Could Help Alzheimer’s Patients Reverse Memory Loss

By Emily Price
January 2, 2018

Most Popular

  • Success
    Meetings are not work, says Southwest Airlines CEO—and he’s taking action, by blocking his calendar every afternoon...
    By Preston Fore
  • Success
    'I had to take 60 meetings': Jeff Bezos says 'the hardest thing I've ever done' was raising the first million dollars...
    By Dave Smith
  • Economy
    America's $38 trillion national debt 'exacerbates generational imbalances' with Gen Z and millennials paying the price,...
    By Eleanor Pringle
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • MPW
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms of Use
  • Single Issues for Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work at Fortune
  • Diversity and Inclusion
  • Terms and Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.